Cancer Drugs Not Working Hard Enough for the Money

Dr Peter Bach attributes the high cost of cancer drugs to the pharmaceutical industry ' s ' government-granted monopoly pricing power, ' saying that benefit to patients is not commensurate with price.

Source: Medscape Oncology - July 10, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts